文献速递肿瘤 PET/CT核素与放射性配体治疗

99mTc-HYNIC-TOC与18F-FDG PET/CT检测混合型Castleman病

A Mixed Variant of Castleman Disease Detected by Somatostatin Receptor Scintigraphy with 99mTc-HYNIC-TOC and 18F-FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2019-01-01

一例50岁女性患者,增强CT发现右下腹富血供腹部肿块,99mTc-HYNIC-TOC生长抑素受体显像示腹部肿块阳性并检出右腋窝中等放射性增高病灶,18F-FDG PET/CT示两处病灶均FDG高摄取,另见右锁骨上区高代谢淋巴结。腹部肿块手术切除后病理示Castleman病,为透明血管型与浆细胞型混合变异型,右腋窝及锁骨上病灶考虑为Castleman病累及。

要点

  • 99mTc-HYNIC-TOC生长抑素受体显像可显示Castleman病病灶阳性。
  • 18F-FDG PET/CT示Castleman病病灶FDG高摄取。
  • 病理证实为透明血管型与浆细胞型混合变异型Castleman病。

核心结论

  • 99mTc-HYNIC-TOC生长抑素受体显像与18F-FDG PET/CT均可检测Castleman病病灶,病理证实为混合型变异。

研究设计与样本

  • 个案报道:一例50岁女性,行增强CT、99mTc-HYNIC-TOC生长抑素受体显像及18F-FDG PET/CT,腹部肿块手术切除后行组织病理学检查。

主要发现

  • 增强CT示右下腹富血供腹部肿块。
  • 99mTc-HYNIC-TOC显像示腹部肿块阳性,并检出右腋窝中等放射性增高病灶。
  • 18F-FDG PET/CT示腹部肿块及右腋窝病灶均FDG高摄取,另见右锁骨上区高代谢淋巴结。
  • 腹部肿块病理示Castleman病,为透明血管型与浆细胞型混合变异型。
  • 右腋窝及锁骨上病灶考虑为Castleman病累及。

临床怎么用

  • 对怀疑Castleman病的富血供腹部肿块,可结合生长抑素受体显像与18F-FDG PET/CT评估病灶分布及累及范围。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 50-year-old woman was found with a hypervascular abdominal mass in the right lower quadrant in contrast-enhanced CT. Somatostatin receptor scintigraphy with Tc-HYNIC-TOC showed positivity of the abdominal mass and detected additional lesion with moderate increased radioactivity in the right axilla. In F-FDG PET/CT, both of the lesions were FDG-avid. A hypermetabolic node in the right supraclavicular fossa was also noted. The histopathological examination of the abdominal mass after surgical resection revealed Castleman disease, a mixed hyaline vascular and plasma cell variant. The right axillary and supraclavicular lesions were considered involvement of Castleman disease.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Pan Q, Zhang X, Luo Y, et al. A Mixed Variant of Castleman Disease Detected by Somatostatin Receptor Scintigraphy with 99mTc-HYNIC-TOC and 18F-FDG PET/CT. Clin Nucl Med. 2019. PMID: 30516666. doi:10.1097/RLU.0000000000002411

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。